|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Provision for credit losses | |||||
| Depreciation and amortization | |||||
| Deferred income tax | |||||
| Stock based compensation | |||||
| Investment securities amortization, net | |||||
| Net loss on sale of investment securities available for sale | |||||
| Net gains on loan and lease sales | |||||
| (Gain) loss on sale of real estate owned | |||||
| Gain on sale of premises and equipment | |||||
| Accretion of loan origination fees | |||||
| Amortization of mortgage-servicing rights | |||||
| ESOP shares expense | |||||
| Increase in cash surrender value of life insurance | |||||
| Loans originated for sale | |||||
| Proceeds on loans sold | |||||
| Net change in | |||||
| Interest receivable | |||||
| Other assets | |||||
| Other liabilities | |||||
| Interest payable | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Net change in interest-bearing time deposits | |||||
| Purchases of securities available for sale | |||||
| Proceeds from maturities and paydowns of securities available for sale | |||||
| Proceeds from sales of securities available for sale | |||||
| Proceeds from maturities and paydowns of securities held to maturity | |||||
| Net change in loans | |||||
| Proceeds from sales of real estate owned | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sale of premises and equipment | |||||
| Purchases of FHLB stock | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Net change in | |||||
| Demand and savings deposits | |||||
| Certificates of deposit | |||||
| Advances by borrowers for taxes and insurance | |||||
| Proceeds from other borrowings | |||||
| Proceeds from FHLB advances | |||||
| Repayment of FHLB advances | |||||
| Repurchase of common stock | |||||
| Proceeds from stock option exercises | |||||
| Dividends paid | |||||
| Net cash provided by financing activities | |||||
| Net Change in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents, Beginning of Period | |||||
| Cash and Cash Equivalents, End of Period | |||||
| Additional Cash Flows and Supplementary Information | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Transfers from loans to other real estate owned | |||||
| Right of use assets obtained in exchange for new operating lease liabilities | |||||
Loading...